相似文献
1
The potential use of liposome-mediated antiviral therapy.
Antiviral Res. 1985 Jun;5(3):179-90. doi: 10.1016/0166-3542(85)90050-6.
2
Selective delivery of drugs encapsulated in liposomes: natural targeting to macrophages involved in various disease states.
J Biol Response Mod. 1983;2(2):97-100.
3
In vitro and in vivo effect of adriamycin therapy on monocyte activation by liposome-encapsulated immunomodulators.
Cancer Res. 1988 Sep 15;48(18):5256-63.
4
Liposome targeting to macrophages: opportunities for treatment of infectious diseases.
Adv Exp Med Biol. 1986;202:171-84. doi: 10.1007/978-1-4684-1259-8_12.
5
Therapy of disseminated melanoma by liposome-activated macrophages.
World J Surg. 1992 Mar-Apr;16(2):270-6. doi: 10.1007/BF02071531.
6
[Immunomodulators--a new generation of antiviral agents].
Eksp Klin Farmakol. 1995 Mar-Apr;58(2):74-8.
7
Human monocytes activated by immunomodulators in liposomes lyse herpesvirus-infected but not normal cells.
Science. 1984 Jun 1;224(4652):1007-9. doi: 10.1126/science.6426057.
8
Human monocyte-mediated cytotoxicity against herpes simplex virus-infected cells: activation of cytotoxic monocytes by free and liposome-encapsulated lymphokines.
J Leukoc Biol. 1985 Apr;37(4):461-72. doi: 10.1002/jlb.37.4.461.
9
Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells.
Mol Membr Biol. 1999 Jan-Mar;16(1):111-8. doi: 10.1080/096876899294832.
10
Drug delivery to macrophages for the therapy of cancer and infectious diseases.
Ann N Y Acad Sci. 1987;507:141-54. doi: 10.1111/j.1749-6632.1987.tb45797.x.
引用本文的文献
1
The systemic activation of macrophages by liposomes containing immunomodulators.
Springer Semin Immunopathol. 1985;8(4):413-28. doi: 10.1007/BF01857394.
2
Liposomes in treatment of infectious diseases.
Pharm Weekbl Sci. 1987 Jun 19;9(3):162-71. doi: 10.1007/BF01967536.
3
Liposomes as carriers of antimicrobial agents.
Antimicrob Agents Chemother. 1987 May;31(5):675-8. doi: 10.1128/AAC.31.5.675.
4
Immunopotentiation of the humoral response by liposomes: encapsulation versus covalent linkage.
Immunology. 1988 Oct;65(2):315-7.
5
Increased efficacy of phosphonoformate and phosphonoacetate inhibition of herpes simplex virus type 2 replication by encapsulation in liposomes.
Antimicrob Agents Chemother. 1988 Jun;32(6):858-64. doi: 10.1128/AAC.32.6.858.
6
Effect of free or liposome-encapsulated muramyl dipeptide on uptake and intracellular survival of Listeria monocytogenes in mouse peritoneal macrophages in vitro.
Eur J Clin Microbiol Infect Dis. 1989 Jul;8(7):603-9. doi: 10.1007/BF01968137.
7
Macrophages and cancer.
Cancer Metastasis Rev. 1990 Feb;8(4):319-51. doi: 10.1007/BF00052607.
8
Comparative efficacy of liposomes containing synthetic bacterial cell wall analogues for tumoricidal activation of monocytes and macrophages.
Cancer Immunol Immunother. 1991;33(5):285-92. doi: 10.1007/BF01756592.
本文引用的文献
1
THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. II. A CELLULAR BASIS FOR THE DEVELOPMENT OF RESISTANCE WITH AGE.
J Exp Med. 1964 Sep 1;120(3):359-74. doi: 10.1084/jem.120.3.359.
2
ASPECTS OF THE PATHOGENESIS OF VIRUS DISEASES.
Bacteriol Rev. 1964 Mar;28(1):30-71. doi: 10.1128/br.28.1.30-71.1964.
3
From the National Institute of Allergy and Infectious Diseases. Summary of a workshop on new and useful techniques in rapid viral diagnosis.
J Infect Dis. 1980 Nov;142(5):793-802. doi: 10.1093/infdis/142.5.793.
4
Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
J Immunol. 1980 Dec;125(6):2454-60.
5
Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines.
Science. 1980 Jun 27;208(4451):1469-71. doi: 10.1126/science.7384789.
6
Dengue virus multiplication in cultures of mouse peritoneal macrophages: effects of macrophage activators.
Microbiol Immunol. 1982;26(8):665-76. doi: 10.1111/j.1348-0421.1982.tb00210.x.
7
Amphotericin B in liposomes: a novel therapy for histoplasmosis.
Am Rev Respir Dis. 1982 May;125(5):610-1. doi: 10.1164/arrd.1982.125.5.610.
8
Treatment of murine cryptococcosis with liposome-associated amphotericin B.
J Infect Dis. 1982 May;145(5):748-52. doi: 10.1093/infdis/145.2.748.
9
Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery.
Cancer Res. 1982 Apr;42(4):1412-22.
10
Antiviral mechanisms of action.
Annu Rev Pharmacol Toxicol. 1980;20:259-84. doi: 10.1146/annurev.pa.20.040180.001355.
Zotero 插件